Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 989 of 6351
-
New combo shows promise against Tough-to-Treat lymphoma
Disease control CompletedThis clinical trial will study brentuximab vedotin with CHP to find out if the drugs work for people who have certain types of peripheral T-cell lymphoma (PTCL). It will also find out what side effects occur when brentuximab vedotin and CHP are used together. A side effect is any…
Phase 2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Radiation boosts standard therapy in advanced breast cancer trial
Disease control Recruiting nowWomen with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (HER)2- metastatic breast cancer are eligible to a randomized trial. Patients receiving standard first line therapy for metastatic HR+ Breast cancer(BC) (letrozole+palbociclib) are randomly assigned to also …
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Sickle cell drug trial in kids halted early – but data may still help
Disease control Stopped earlyThis study is a Phase 3, randomized, double-blind, placebo-controlled study of voxelotor in pediatric participants, aged ≥ 2 to \< 15 years old, with Sickle Cell Disease. The primary objective is to evaluate the effect of voxelotor on the TCD (Transcranial Doppler Ultrasound) mea…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug cocktail aims to shrink melanoma before surgery
Disease control OngoingIn many cancers, early stage diagnosis and early treatment offers the best chance of a prolonged recurrence free- and overall survival. In stage III/IV resectable melanoma, an opportunity exists to improve outcomes with the addition of neoadjuvant and adjuvant systemic therapy as…
Phase 2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Lung cancer trial questions need for immediate brain radiation in asymptomatic patients
Disease control Recruiting nowTyrosine Kinase Inhibitors (TKIs) especially higher generation TKI have higher CNS penetration rates and have shown favorable response rates in brain metastases. Brain radiotherapy/surgery is the standard treatment in brain metastases especially symptomatic metastases, however, t…
Phase 3 • Sponsor: Tata Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 15:49 UTC
-
Pancreatic cancer study tests best radiation dose to extend life
Disease control CompletedThe aim of this study is to compare the safety and efficacy of SBRT in LAPC with different biological effective dose (BED) (\<70Gy Vs.\>70Gy ) , to identify a dose range that could achieve better survival benefit and minimize the toxicity of radiotherapy.
Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New combo therapy shows promise for rare eye cancer
Disease control CompletedThe purpose of this research is to test if a combination treatment of nivolumab and relatlimab will result in tumor reduction in patients with metastatic uveal melanoma.
Phase 2 • Sponsor: Jose Lutzky, MD • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for advanced prostate cancer: radioactive drug vs standard therapy
Disease control OngoingResearchers in this study want to compare how well drug radium-223 dichloride (Xofigo) and androgen receptor pathway inhibitor (ARPI) therapy work in participants with prostate gland cancer which has spread to the bone and progressed on or after one line of ARPI therapy. Meanwhil…
Phase 4 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Gene therapy trial targets inherited dementia
Disease control OngoingStudy J4B-MC-OKAA is a Phase 1/2, multi-center, open-label ascending dose, first-in-human study that will evaluate the safety and effect of intra-cisternal LY3884963 administration on progranulin protein (PGRN) levels in patients with frontotemporal dementia with progranulin muta…
Phase 1/2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Virtual reality rehab aims to bring stroke therapy home
Disease control CompletedStroke represents one of the main causes of adult disability and will be one of the main contributors to the burden of disease in 2030. However, the healthcare systems are not able to respond to the current demand let alone its future increase. There is a need to deploy new appro…
Sponsor: Institute for Bioengineering of Catalonia • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo targets KRAS lung cancer in patients who Can't have surgery
Disease control OngoingTo determine the optimal objective response rate (ORR) of tislelizumab combined with albumin-bound paclitaxel and platinum agents in patients with KRAS-mutant lung cancer who are ineligible for curative surgery
Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Sound waves open Brain's shield to attack deadly tumors
Disease control CompletedThe purpose of this study is to evaluate the safety and feasibility of the Exablate Model 4000 Type 2 system when used as a tool to open the blood-brain-barrier (BBB) in subjects with recurrent glioblastoma (rGBM) undergoing carboplatin monotherapy.
Phase 1/2 • Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for lung cancer: personalized drug cocktails before surgery
Disease control Recruiting nowThis trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors that meet protocol-specified biomarker criteria.
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for kids with tough leukemia: drug combo trial launches
Disease control Recruiting nowTreatment with intensive chemotherapy in AML results in approximately 70% survival in newly diagnosed patients. Prognosis at relapse is worse and is in the 30-40% range. Relapse treatment generally consists of one course of fludarabine, cytarabine and liposomal daunorubicin (FLAG…
Phase 1 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 13:49 UTC
-
Brain tumor surgery may get a boost: chemo wafer could replace radiation
Disease control Recruiting nowThis study is being done to see if adding GLIADEL to the site where the tumor was removed works as well as just having the tumor removed with radiation treatment done within six weeks after the surgery to keep the cancer from coming back.
Phase 2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Prostate cancer trial combines four treatments to fight recurrence
Disease control OngoingThe purpose of this study is to establish the maximum tolerable dose of niraparib when combined with prostate stereotactic body radiotherapy (SBRT), abiraterone, leuprolide, and prednisone (the phase 1 portion of the study) and determine 3-year biochemical PSA recurrence free-sur…
Phase 1/2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug duo takes on rare cancer
Disease control OngoingThe purpose of this study is to find out whether combining the study drugs rucaparib and nivolumab may be an effective treatment for advanced and/or metastatic LMS, and whether the study treatment works as well as the standard chemotherapy for this type of cancer.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
A shot of numbing relief: could trigger point injections cut opioid use after neck surgery?
Symptom relief CompletedTo achieve appropriate exposure for an anterior neck surgery (for example an Anterior Cervical Discectomy and Fusion or ACDF), patients are positioned supine with their neck extended. Due to being in this position, patients frequently complain of posterior neck stiffness and pain…
Phase 4 • Sponsor: George Washington University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Which blood pressure drug spares the lungs during heart surgery?
Disease control CompletedThe relative increase in the mPAP with the same unit increase in MAP adjusted for baseline, and RV function assessed by GLS, between VP and NE in patients with normal and increased pulmonary artery pressure, who require vasopressor support during cardiac surgery.
Phase 3 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Triple-Drug cocktail shows promise for rare kidney cancers
Disease control OngoingThis research study will assess whether cabozantinib, nivolumab and ipilimumab in combination are safe and effective in slowing down the growth of kidney cancer(renal cell carcinoma or RCC) that has advanced or spread to other areas the body.
Phase 2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC